Glimicef, Products

GLIMICEF M2

Active Ingredients:
- Glimepiride: 2 mg
- Metformin Hydrochloride (Extended-Release): 500 mg

Prescription Status: Prescription-only medication (Rx)
Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for the treatment of type 2 diabetes mellitus.

Blood Sugar Control in Type 2 Diabetes:
- Glimepiride: A sulfonylurea that increases insulin secretion from the pancreas, effectively lowering blood glucose levels. The 2 mg dose is intended for patients needing a higher insulin-stimulating effect.
- Metformin Hydrochloride (ER): A biguanide that reduces hepatic glucose production, enhances insulin sensitivity, and improves peripheral glucose uptake. The extended-release formulation ensures a steady release of medication, minimizing gastrointestinal side effects and improving patient tolerance.
Dual Action: The combination of Glimepiride and Metformin provides a complementary approach to managing blood sugar levels, particularly for patients who require both increased insulin production and improved insulin sensitivity.
Reduced Risk of Complications: Effective management of blood glucose levels with this combination reduces the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, nephropathy, and retinopathy.
Simplified Regimen: The combination of two medications in a single tablet facilitates better patient compliance, which is crucial for the effective management of type 2 diabetes.